Prune exopolyphosphatase 1 (PRUNE1) is a short-chain phosphatase that is part of the aspartic acid-histidine-histidine (DHH) family of proteins. PRUNE1 is highly expressed in the central nervous system and is crucially involved in neurodevelopment, cytoskeletal rearrangement, cell migration, and proliferation. Recently, biallelic PRUNE1 variants have been identified in patients with neurodevelopmental disorders, hypotonia, microcephaly, variable cerebral anomalies, and other features. PRUNE1 hypomorphic mutations mainly affect the DHH1 domain, leading to an impactful decrease in enzymatic activity with a loss-of-function mechanism. In this review, we explored both the clinical and radiological spectrum related to PRUNE1 pathogenic variants described to date. Specifically, we focused on neuroradiological findings that, together with clinical phenotypes and genetic data, allow us to best characterize affected children with diagnostic and potential prognostic implications.

Neuroimaging in PRUNE1 syndrome: a mini-review of the literature / Scorrano, G.; Laura, B.; Spiaggia, R.; Basile, A.; Palmucci, S.; Foti, P. V.; David, E.; Marinangeli, F.; Mascilini, I.; Corsello, A.; Comisi, F.; Vittori, A.; Salpietro, V.. - In: FRONTIERS IN NEUROLOGY. - ISSN 1664-2295. - 14:(2023). [10.3389/fneur.2023.1301147]

Neuroimaging in PRUNE1 syndrome: a mini-review of the literature

David E.;Marinangeli F.;Mascilini I.;
2023

Abstract

Prune exopolyphosphatase 1 (PRUNE1) is a short-chain phosphatase that is part of the aspartic acid-histidine-histidine (DHH) family of proteins. PRUNE1 is highly expressed in the central nervous system and is crucially involved in neurodevelopment, cytoskeletal rearrangement, cell migration, and proliferation. Recently, biallelic PRUNE1 variants have been identified in patients with neurodevelopmental disorders, hypotonia, microcephaly, variable cerebral anomalies, and other features. PRUNE1 hypomorphic mutations mainly affect the DHH1 domain, leading to an impactful decrease in enzymatic activity with a loss-of-function mechanism. In this review, we explored both the clinical and radiological spectrum related to PRUNE1 pathogenic variants described to date. Specifically, we focused on neuroradiological findings that, together with clinical phenotypes and genetic data, allow us to best characterize affected children with diagnostic and potential prognostic implications.
2023
PRUNE1; delayed myelination; enzymatic activity; neurodevelopmental disorder; neurogenesis
01 Pubblicazione su rivista::01g Articolo di rassegna (Review)
Neuroimaging in PRUNE1 syndrome: a mini-review of the literature / Scorrano, G.; Laura, B.; Spiaggia, R.; Basile, A.; Palmucci, S.; Foti, P. V.; David, E.; Marinangeli, F.; Mascilini, I.; Corsello, A.; Comisi, F.; Vittori, A.; Salpietro, V.. - In: FRONTIERS IN NEUROLOGY. - ISSN 1664-2295. - 14:(2023). [10.3389/fneur.2023.1301147]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1725578
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 1
social impact